Skip to main content

AI-powered pathological cancer diagnostics


MindPeak is an innovative start-up that builds diagnostic support tools for cancer diagnosis. Our Artificial Intelligence (AI) software analyses biopsy slides within seconds to find tumour regions and quantify tumour markers to prepare them for visual inspection by the pathologist. In 2018, the number of diagnosed cancer cases has grown to 18 million globally.
Consequently, the demand for cancer diagnosis to determine appropriate treatment has never been higher. Cancer diagnosis nowadays is a very time-consuming process and depends heavily on the knowledge and experience of specialised pathologists. Unfortunately, the number of experts can no longer meet the quickly increasing demand. As a result, patients must wait longer than necessary for their diagnosis.
To overcome this challenge, MindPeak provides solutions based on deep learning to support pathologists in their diagnosis. Patients benefit from increased accuracy and a faster turn around time of diagnosis as well as reduced costs. The key USP of our AI is its reliability in the clinical context with its variations across and within labs. Funding from the EIC Accelerator will help us with a successful and fast go-to-market of our solutions that cover crucial improvements for cancer patients. With our technology, we address the market for pathology with a current size of $17.3 bn worldwide and an annual growth rate of 6.5%.

Field of science

  • /social sciences/economics and business/business and management/commerce
  • /medical and health sciences/clinical medicine/oncology/cancer
  • /natural sciences/computer and information sciences/artificial intelligence/machine learning/deep learning

Call for proposal

See other projects for this call

Funding Scheme

SME-2b - SME Instrument (grant only and blended finance)


Zirkusweg 2
20359 Hamburg
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
EU contribution
€ 1 372 378